Pharma-Bio Serv, Inc. (PBSV)
| Market Cap | 16.07M |
| Revenue (ttm) | 10.60M |
| Net Income (ttm) | -2.60M |
| Shares Out | 22.95M |
| EPS (ttm) | -0.09 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $0.15 (21.43%) |
| Ex-Dividend Date | Feb 24, 2022 |
| Volume | 925 |
| Open | 0.700 |
| Previous Close | 0.700 |
| Day's Range | 0.700 - 0.700 |
| 52-Week Range | 0.580 - 1.170 |
| Beta | 0.40 |
| Analysts | n/a |
| Price Target | 2.15 (+207.1%) |
| Earnings Date | n/a |
About PBSV
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto R... [Read more...]
News
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2022
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting fi...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting f...
Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer suppo...
Pharma-Bio Serv Announces Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / November 15, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer suppo...
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer supp...
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project manag...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting f...
Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Divi...
DORADO, PUERTO RICO / ACCESSWIRE / January 5, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting ...